Research and Markets announces the addition of the "Transdermal Hormone Replacement : Products, Players, Markets …

This report available from Research and Markets analyzes and evaluates the global market opportunity for transdermal hormone replacement and assesses the probable impact of evolving regulatory, economic and demand factors.

Dublin, Ireland (PRWEB) March 20, 2013

For the past two decades, the healthcare industry has responded to this clinical need by developing, testing and marketing hormone replacement therapy (HRT) products. Because of their ease-of-use and dosing characteristics, drug developers are continuing to turn to transdermal delivery systems for HRT products. There are more than 40 million post-menopausal women in the United States alone, and this group is expected to grow by 50% by 2020. With the aging of the population worldwide, conditions and diseases such as menopause, osteoporosis and heart disease, which may benefit from hormone replacement therapy, are expected to become significantly more prevalent. The industry continues to attract interest in the form of new participants and products.

While the global market continues to be dominated by the FDA-approved HRT products of major pharmaceutical firms, regional markets are a bit more competitive, and present unique challenges to transdermal HRT sector participants.

Highlights:

For more information please visit http://www.researchandmarkets.com/research/c4mvd9/transdermal

Research and Markets

Laura Wood, Senior Manager.

Email: press(at)researchandmarkets(dot)com

Phone: +35314151241

See more here:
Research and Markets announces the addition of the "Transdermal Hormone Replacement : Products, Players, Markets ...